KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 101 filers reported holding KARUNA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,491 | -91.5% | 340 | -89.1% | 0.00% | -100.0% |
| Q2 2023 | $678,524 | +724.6% | 3,129 | +590.7% | 0.00% | – |
| Q1 2023 | $82,283 | -75.9% | 453 | -74.0% | 0.00% | -100.0% |
| Q4 2022 | $342,107 | -78.6% | 1,741 | -86.2% | 0.00% | -66.7% |
| Q2 2022 | $1,601,000 | +1077.2% | 12,655 | +1081.6% | 0.00% | – |
| Q1 2022 | $136,000 | -87.0% | 1,071 | -86.6% | 0.00% | -100.0% |
| Q4 2021 | $1,043,000 | +1411.6% | 7,964 | +1307.1% | 0.00% | – |
| Q3 2021 | $69,000 | -90.1% | 566 | -90.8% | 0.00% | -100.0% |
| Q2 2021 | $699,000 | -6.7% | 6,133 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $749,000 | +142.4% | 6,233 | +105.2% | 0.00% | 0.0% |
| Q4 2020 | $309,000 | +291.1% | 3,037 | +328.3% | 0.00% | – |
| Q2 2020 | $79,000 | +92.7% | 709 | +23.1% | 0.00% | – |
| Q1 2020 | $41,000 | – | 576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |